OTC Markets OTCQB - Delayed Quote USD
Willow Biosciences Inc. (CANSF)
0.0050
+0.0016
+(47.06%)
At close: April 28 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 30.48M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Savile (Christopher Kenneth Ph.D.) Director of Issuer | Acquisition or disposition in the public market at price 0.07 per share. | Direct | 3,700 | Sep 5, 2024 |
| Doupe, Travis Senior Officer of Issuer | Acquisition or disposition in the public market at price 0.06 per share. | Direct | 3,069 | Aug 14, 2024 |
| Archibald (Donald) Director of Issuer | Acquisition or disposition carried out privately at price 0.07 per share. | Direct | 21,900 | Jul 18, 2024 |
| Choudhary (Patricia Ranija) Director of Issuer | Acquisition or disposition carried out privately at price 0.07 per share. | Direct | 21,900 | Jul 18, 2024 |
| Doupe, Travis Senior Officer of Issuer | Acquisition or disposition under a prospectus exemption at price 0.07 per share. | Direct | 21,900 | Jul 18, 2024 |
| Lalonde (James Joseph) Director of Issuer | Acquisition or disposition carried out privately at price 0.07 per share. | Direct | 21,900 | Jul 18, 2024 |
| Savile (Christopher Kenneth Ph.D.) Director of Issuer | Acquisition or disposition carried out privately at price 0.07 per share. | Direct | 21,900 | Jul 18, 2024 |
| Archibald (Donald) Director of Issuer | Conversion or exchange at price 0.08 per share. | Direct | 4,393 | Jul 3, 2024 |
| Choudhary (Patricia Ranija) Director of Issuer | Conversion or exchange at price 0.08 per share. | Direct | 4,393 | Jul 3, 2024 |
| Doupe, Travis Senior Officer of Issuer | Conversion or exchange at price 0.08 per share. | Direct | 5,052 | Jul 3, 2024 |
| Lalonde (James Joseph) Director of Issuer | Conversion or exchange at price 0.08 per share. | Direct | 4,393 | Jul 3, 2024 |
| Savile (Christopher Kenneth Ph.D.) Director of Issuer | Conversion or exchange at price 0.08 per share. | Direct | 4,393 | Jul 3, 2024 |
| Asadorian (Raffi) Director of Issuer | Exercise of rights at price 0.06 per share. | Direct | 413 | May 27, 2024 |
| Choudhary (Patricia Ranija) Director of Issuer | Exercise of rights at price 0.07 per share. | Direct | 2,176 | May 16, 2024 |
| Doupe, Travis Senior Officer of Issuer | Exercise of rights at price 0.07 per share. | Direct | 2,718 | May 16, 2024 |
| Savile (Christopher Kenneth Ph.D.) Director of Issuer | Exercise of rights at price 0.07 per share. | Direct | 2,718 | May 16, 2024 |
Related Tickers
FFNTF 4Front Ventures Corp.
0.0020
0.00%
FLHLF Filament Health Corp.
0.0248
+12.73%
TLLTF TILT Holdings Inc.
0.0070
+20.69%
CANN Trees Corporation
0.0341
+0.29%
FLGC Flora Growth Corp.
0.5870
+1.21%
LABS.TO MediPharm Labs Corp.
0.0900
0.00%
SXTC China SXT Pharmaceuticals, Inc.
2.4300
+6.11%
ACB Aurora Cannabis Inc.
4.6800
-2.70%
SNOA Sonoma Pharmaceuticals, Inc.
3.9400
-6.86%
WEED.TO Canopy Growth Corporation
1.8400
-5.64%